Researchers from the University of Oxford and their partners have today reported findings from a Phase IIb trial of a candidate malaria vaccine, R21/Matrix-M, which demonstrated high-level efficacy of 77% over 12-months of follow-up. In their findings (posted on SSRN/Preprints with The Lancet) they note that they are the first...
Full ArticleMalaria Vaccine Becomes First To Achieve WHO-Specified 75% Efficacy Goal
Eurasia Review
0 shares
2 views
You might like
Related news coverage
New malaria vaccine first to reach WHO efficacy demand
Deutsche Welle
Malaria kills hundreds of thousands of children each year. Now, an early stage malaria vaccine trial in Africa has shown..
-
New malaria vaccine proves highly effective and COVID shows how quickly it could be deployed
MENAFN.com
-
A new malaria vaccine has proven 77 percent effective in trials on infants, British researchers said Friday, in what could prove to be a...
Upworthy
-
News24.com | 'Landmark' advance as malaria vaccine first to hit WHO goal
News24
-
Africa: Malaria Vaccine Becomes First to Achieve WHO-specified 75% Efficacy Goal
allAfrica.com
Advertisement
More coverage
Malaria vaccine proved 'highly effective' during clinical trials
A malaria vaccine developed by researchers from the University of Oxford was found to have a high-level efficacy of 77 per cent,..
euronews